NCT06540066 2026-03-16A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid TumorsBeOne MedicinesPhase 1 Terminated35 enrolled
NCT05935098 2026-03-13BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid TumorsBeOne MedicinesPhase 1 Terminated99 enrolled
NCT06005974 2026-02-23A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC MutationRecursion Pharmaceuticals Inc.Phase 2 Terminated18 enrolled